These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2122961

  • 1. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs.
    Datiles MB, Kador PF, Kashima K, Kinoshita JH, Sinha A.
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2201-4. PubMed ID: 2122961
    [Abstract] [Full Text] [Related]

  • 2. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG, Laver NM, Jacot JL, Glover JP.
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [Abstract] [Full Text] [Related]

  • 3. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Sato S, Mori K, Wyman M, Kador PF.
    Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
    [Abstract] [Full Text] [Related]

  • 4. Galactose-induced retinal microangiopathy in rats.
    Kern TS, Engerman RL.
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
    Tilton RG, Pugliese G, LaRose LS, Faller AM, Chang K, Province MA, Williamson JR.
    J Diabet Complications; 1991 Feb; 5(4):230-7. PubMed ID: 1779018
    [Abstract] [Full Text] [Related]

  • 10. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N, Tsui J, Johnson M.
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [Abstract] [Full Text] [Related]

  • 11. Progression of sugar cataract in the dog.
    Sato S, Takahashi Y, Wyman M, Kador PF.
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1925-31. PubMed ID: 1903366
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effect of orally administered aldose reductase inhibitor SNK-860 on corneal polyol accumulation in galactose-fed rats.
    Kubo E, Nakamura S, Tsuzuki S, Takahashi Y, Akagi Y, Mizuno K, Matsubara A.
    Graefes Arch Clin Exp Ophthalmol; 1999 Sep; 237(9):758-62. PubMed ID: 10447652
    [Abstract] [Full Text] [Related]

  • 13. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
    Das A, Frank RN, Zhang NL, Samadani E.
    Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
    [Abstract] [Full Text] [Related]

  • 14. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors.
    Lightman S, Rechthand E, Terubayashi H, Palestine A, Rapoport S, Kador P.
    Diabetes; 1987 Nov; 36(11):1271-5. PubMed ID: 3117606
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Iris vasculopathy in galactose-fed rats.
    Caspers-Velu LE, Wadhwani KC, Rapoport SI, Kador PF.
    Exp Eye Res; 1999 Feb; 68(2):211-21. PubMed ID: 10068486
    [Abstract] [Full Text] [Related]

  • 17. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs.
    Kador PF, Takahashi Y, Akagi Y, Neuenschwander H, Greentree W, Lackner P, Blessing K, Wyman M.
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1916-21. PubMed ID: 12036999
    [Abstract] [Full Text] [Related]

  • 18. Corneal endothelial morphology in the rat. Effects of aging, diabetes, and topical aldose reductase inhibitor treatment.
    Meyer LA, Ubels JL, Edelhauser HF.
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):940-8. PubMed ID: 2967259
    [Abstract] [Full Text] [Related]

  • 19. Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Neuenschwander H, Takahashi Y, Kador PF.
    J Ocul Pharmacol Ther; 1997 Dec; 13(6):517-28. PubMed ID: 9436155
    [Abstract] [Full Text] [Related]

  • 20. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors.
    Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH.
    Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.